61 3 Epidemiology and control of DM-TB Comorbidity References 1. World Health Organisation. Novel Coronavirus (2019-nCoV) SITUATION REPORT - 1. 21 January 2020 Geneva: WHO; 2020 [cited 2021 30 October]. Available from: https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4 2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020. 3. Johns Hopkins University. Coronavirus Resource Center 2021 [cited 2021 20 October]. Available from: https://coronavirus.jhu.edu/map.html. 4. World Health Organisation. Coronavirus disease (COVID-19) Situation Report – 114. May 13 2020 Geneva: WHO; 2020 [cited 2021 25 October]. Available from: https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200513-covid-19-sitrep-114.pdf?sfvrsn=17ebbbe_4. 5. Jordan RE, Adab P, Cheng K. Covid-19: risk factors for severe disease and death. British Medical Journal Publishing Group; 2020. 6. World Health Organisation. Global Tuberculosis Report 2020 Geneva: WHO; 2020 [cited 2021 30 October]. Available from: https://www.who.int/tb/publications/global_report/en/. 7. The Joint United Nations Programme on HIV/AIDS. Global HIV & AIDS Statistics - 2019 Factsheet: UNAIDS; 2019 [cited 2021 30 October]. Available from: https://www.unaids.org/sites/default/files/ media_asset/UNAIDS_FactSheet_en.pdf. 8. Allen L. Are we facing a noncommunicable disease pandemic? Journal of Epidemiology and Global Health. 2017;7(1):5-9. 9. World Health Organisation. Global Action Plan and the Prevention and Control of NonCommunicable Diseases, 2013–2020. Geneva: WHO; 2013 [cited 2021 20 October]. Available from: https://www.who.int/nmh/events/ncd_action_plan/en/. 10. World Health Organisation. Noncommunicable Diseases: Key facts Geneva: WHO; 2018 [cited 2021 20 October]. Available from: https://www.who.int/es/news-room/fact-sheets/detail/ noncommunicable-diseases. 11. Reubi D, Herrick C, Brown T. The politics of non-communicable diseases in the global South. Health & Place. 2016;39:179-87. 12. Niazi AK, Kalra S. Diabetes and tuberculosis: a review of the role of optimal glycemic control. Journal of Diabetes & Metabolic Disorders. 2012;11(1):28. 13. Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, et al. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. AIDS (London, England). 2018;32 Suppl 1(Suppl 1):S5-S20. 14. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet infectious diseases. 2009;9(12):737-46. 15. Mendenhall E, Kohrt BA, Norris SA, Ndetei D, Prabhakaran D. Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations. The Lancet. 2017;389(10072):951-63. 16. Magee MJ, Salindri AD, Kyaw NTT, Auld SC, Haw JS, Umpierrez GE. Stress hyperglycemia in patients with tuberculosis disease: epidemiology and clinical implications. Current diabetes reports. 2018;18(9):1-10.
RkJQdWJsaXNoZXIy MTk4NDMw